Biotech · Private company
Oncotelic Inc.
Track this companyFree. Adds Oncotelic Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- mFOLFIRINOXPhase 3 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OT-101Phase 3 · Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OT-101Phase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint InhibitionPHASE2 · NOT_YET_RECRUITING · started Jun 1, 2025ClinicalTrials.gov NCT05425576 · fetched Nov 12, 2026
- A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic CancerPHASE2_PHASE3 · RECRUITING · started May 1, 2024ClinicalTrials.gov NCT06079346 · fetched Nov 12, 2026